-
![Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor](/abs-image/US/2010/08/10/US07772247B2/abs.jpg.150x150.jpg)
1.发明授权Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor 有权取代的噻吩并[3,2-d]吡啶作为VEGF受体和HGF受体的抑制剂公开(公告)号：US07772247B2
公开(公告)日：2010-08-10
申请号：US11191617
申请日：2005-07-28
申请人： Arkadii Vaisburg , Stephen William Claridge , Franck Raeppel , Oscar Mario Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Llewellyn
发明人： Arkadii Vaisburg , Stephen William Claridge , Franck Raeppel , Oscar Mario Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Llewellyn
IPC分类号： C07D495/04 , A61K31/4365 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/10 , C07D223/04 , A61P35/04 , A61P9/10 , A61K31/519 , C07D487/04 , C07D401/04 , C07D471/04
CPC分类号： C07D495/04 , C07D471/04 , C07D487/04
摘要： The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions
摘要翻译： 本发明涉及VEGF受体信号传导和HGF受体信号传导的抑制。 本发明提供了用于抑制VEGF受体信号传导和HGF受体信号传导的化合物和方法。 本发明还提供了治疗细胞增殖性疾病和病症的组合物和方法
-
公开(公告)号：US20060074056A1
公开(公告)日：2006-04-06
申请号：US11191617
申请日：2005-07-28
申请人： Arkadii Vaisburg , Stephen Claridge , Franck Raeppel , Oscar Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Llewellyn
发明人： Arkadii Vaisburg , Stephen Claridge , Franck Raeppel , Oscar Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Llewellyn
IPC分类号： A61K31/655 , A61K31/522 , C07D473/02 , C07D487/02
CPC分类号： C07D495/04 , C07D471/04 , C07D487/04
摘要： The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions
摘要翻译： 本发明涉及VEGF受体信号传导和HGF受体信号传导的抑制。 本发明提供了用于抑制VEGF受体信号传导和HGF受体信号传导的化合物和方法。 本发明还提供了治疗细胞增殖性疾病和病症的组合物和方法
-
公开(公告)号：US20100216766A1
公开(公告)日：2010-08-26
申请号：US12775090
申请日：2010-05-06
申请人： Arkadii Vaisburg , Stephen William Clarige , Franck Raepael , Oscar Mario Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Liewellyn
发明人： Arkadii Vaisburg , Stephen William Clarige , Franck Raepael , Oscar Mario Saavedra , Naomy Berstein , Marie-Claude Granger , Lijie Zhan , Amal Wahhab , David Liewellyn
IPC分类号： A61K31/4365 , A61K31/5377 , A61K31/506 , A61K31/55 , A61K31/497 , A61K31/437 , A61K31/519 , A61P35/00
CPC分类号： C07D495/04 , C07D471/04 , C07D487/04
摘要： The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions
摘要翻译： 本发明涉及VEGF受体信号传导和HGF受体信号传导的抑制。 本发明提供了用于抑制VEGF受体信号传导和HGF受体信号传导的化合物和方法。 本发明还提供了治疗细胞增殖性疾病和病症的组合物和方法
-
-
搜索结果
3 条记录 (耗时 0.044 秒)
